Volume 70, Issue 3, Pages (March 2019)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 53, Issue 1, Pages (July 2010)
Volume 46, Issue 3, Pages (March 2007)
Cerebral pulsatility index by transcranial Doppler sonography predicts the prognosis of patients with fulminant hepatic failure  Manri Kawakami, Masahiko.
The impact of hepatitis E in the liver transplant setting
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen?  Patrick Marcellin, E. Jenny Heathcote,
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis  Wichit Srikureja,
Volume 66, Issue 3, Pages (March 2017)
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Volume 51, Issue 6, Pages (December 2009)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Living donor liver transplantation: is the hype over?
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Miriam L. Cuarterolo, Mirta E. Ciocca, Susana I. López, María T. G
AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.
Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure”  Rakhi Maiwall,
Autoimmune hepatitis: A life-long disease
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 62, Issue 3, Pages (March 2015)
Acute hepatitis C: Current status and remaining challenges
Genomic risk of hepatitis C-related hepatocellular carcinoma
Andres Cardenas, Pere Ginès  Journal of Hepatology 
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Giovanni Addolorato, Antonio Mirijello, Pablo Barrio, Antoni Gual 
Economics of chronic hepatitis B and hepatitis C
The changing role of beta-blocker therapy in patients with cirrhosis
Volume 65, Issue 2, Pages (August 2016)
EASL Clinical Practice Guidelines on hepatitis E virus infection
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Volume 67, Issue 5, Pages (November 2017)
Immigration and viral hepatitis
HCV targeting of patients with cirrhosis
The impact of intestinal microflora on serum bilirubin levels
Volume 38, Issue 1, Pages (January 2003)
Volume 63, Issue 1, Pages (July 2015)
Volume 51, Issue 2, Pages (August 2009)
Chronic hepatitis B in children and adolescents
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
Volume 62, Issue 3, Pages (March 2015)
New trials and results in systemic treatment of HCC
Liver transplantation in children
Reply to: “Flow cytometry makes all the difference”
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
The relationship between age and fat infiltration in liver and muscle
U.P. Neumann, M. Biermer, D. Eurich, P. Neuhaus, T. Berg 
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Volume 70, Issue 3, Pages 564-566 (March 2019) Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?  Mar Riveiro-Barciela, Eva Muñoz-Couselo, Jesús Fernandez-Sojo, Nely Diaz-Mejia, Rafael Parra-López, María Buti  Journal of Hepatology  Volume 70, Issue 3, Pages 564-566 (March 2019) DOI: 10.1016/j.jhep.2018.10.020 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Clinical and analytical follow-up of acute liver failure secondary to immune-mediated hepatitis related to ipilimumab. Blood tests performed before the second infusion of ipilimumab (11 October) showed completely normal liver function. Twenty days later, the patient consulted for jaundice. At that time she was conscious and aware, but the analyses showed severe acute hepatitis with coagulopathy, aspartate aminotransferase >4,000 IU/ml and total bilirubin at 8 mg/dl. Despite high doses of steroids (2 mg/kg/day) and mycophenolate mofetil (1.5 mg/day), bilirubin level continued to increase and coagulopathy worsened. Three days after admission, the patient developed hepatic encephalopathy. Plasma exchange was initiated and performed every other day, with progressive clinical and analytical improvement. In the boxes: Duration of HE (hepatic encephalopathy) and plasma exchange therapy. Journal of Hepatology 2019 70, 564-566DOI: (10.1016/j.jhep.2018.10.020) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions